Confirmation

EP4061358

ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS

  • :
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • :
    20.11.2020
  • :
    28.5.2025
  • :
    20888950.1
  • :
    19.11.2040
  • :
    19.11.2025
  • :
    ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS

20.11.2020
28.5.2025
19.11.2025
  • :
    Arena Pharmaceuticals, Inc.
  • :
    66 Hudson Boulevard East, New York, NY 10001-2192, US
  • :
    KOMORI-OCCHICONE, Heather, Kiyomi
  • :
    San Diego, CA 92129, US
  • :
    NGUYEN-CLEARY, Thai, Curtis
  • :
    Carlsbad, CA 92009, US
  • :
    YU, Jin
  • :
    Tuscon, AZ 85045, US
  • :
    201962938008 P
  • :
    20.11.2019
  • :
    US
  • :
    US2020061653
  • :
    20.11.2020
  • :
    A61K 31/403, A61P 1/00, A61P 1/04, C07D 209/94, A61K 31/404, A61K 9/20